A STUDY ON THEPRODUCTION OF E2 RECOMBINANT ANTIGEN FROM CLASSICAL SWINE FEVER VIRUS BY USING THE PICHIA PASTORIS EXPRESSION SYSTEM
About this article
Received: 22/08/22                Revised: 16/09/22                Published: 16/09/22Abstract
Keywords
Full Text:
PDF (Tiếng Việt)References
[1] S. Edwards, “Survival and inactivation of classical swine fever virus,” Veterinary Microbiology, vol. 73, pp. 175-181, 2000.
[2] V. Moennig, “Introduction to classical swine fever virus disease and control policy,” Veterinary Microbiology,vol. 73, pp. 93-102, 2000.
[3] B. Zhou, K. Liu, Y. Jiang, J. C. Wei, and P. Y. Chen, “Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response,” Virology Journal, vol. 8, pp. 1-7, 2011.
[4] G. R. Risatti, L. G. Holinka, I. Fernandez Sainz, C. Carrillo, Z. Lu, and M. V. Borca, “N-Linked Glycosylation Status of Classical Swine Fever Virus Strain Brescia E2 Glycoprotein Influences Virulence in Swine,” Journal of Virology, vol. 81, pp. 924-933, 2007.
[5] I. Leifer, N. Ruggli, and S. Blome, “Approaches to define the viral genetic basis of classical swine fever virus virulence,” Virology, vol. 438, pp. 51-55, 2013.
[6] P. A. van Rijn, H. G. P. van Gennip, E. J. de Meijer, and R. J. M. Moormann, “Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia,” Journal of Virology, vol. 14, pp. 2053-2060, 1993.
[7] R. Daly and M. T. Hearn, “Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production,” Journal of Molecular Recognition, vol. 18, pp. 119-138, 2005.
[8] W. Zhang, M. A. Bevins, B. A. Plantz, L. A. Smith, and M. M. Meagher, “Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy‐chain fragment C of botulinum neurotoxin, serotype A,” Biotechnology and Bioengineering, vol. 70, pp. 1-8, 2000.
[9] M. Romanos, “Advances in the use of Pichia pastoris for high-level gene expression,” Current Opinion in biotechnology, vol. 6, pp. 527-533, 1995.
[10] X. Zhou, Y. Yu, J. Tao, and L. Yu, “Production of LYZL6, a novel human c-type lysozyme, in recombinant Pichia pastoris employing high cell density fed-batch fermentation,” Journal of bioscience and bioengineering, vol. 118, pp. 420-425, 2014.
[11] X. Han, X. Liu, Y. Zhang, Y. Zhang, and Q. Xie, “Codon optimization and expression in Pichia pastoris of E2 gene of classical swine fever virus,” Wei Sheng wu xue bao = Acta Microbiologica Sinica, vol. 43, pp. 560-568, 2003.
[12] L. Ding, W. Junchen, C. Jin, Z. Dong, Z. Yuanpeng, Q. Xuwen, Y. Xiaoming, Z. Qisheng, and H. Jibo, “Optimized expression of classical swine fever virus E2 protein via combined strategy in Pichia pastoris,” Protein Expression and Purification,vol. 167, pp. 105527, 2020.
[13] Invitrogen, “Pichia expression vectors for constitutive expression and purification of recombinant proteins,” Catalog, vol. 1, pp. 26, 2010.
[14] N. K. Khatri and F. Hoffmann, “Impact of methanol concentration on secreted protein production in oxygen‐limited cultures of recombinant Pichia pastoris,”Biotechnology and Bioengineering, vol. 93, pp. 871-879, 2006.
[15] T. I. Potgieter, M. Cukan, J. E. Drummond, N. R.Houston-Cummings, Y.Jiang, and M. d’Anjou, “Production of monoclonal antibodies by glycoengineered Pichia pastoris,” Journal of biotechnology, vol. 139, pp. 318-325, 2009.
[16] Y.Taguchi and H. M.Schätzl, “Small-scale Triton X-114 extraction of hydrophobic proteins,” Bio-protocol, vol. 4, p. 1139, 2014.
[17] E. Z. Lang, K. R. Rupprecht, T. D. Rae, and J. R. Fishpaugh, “Evaluation of rapid western blot incubation system,” The FASEB Journal, vol. 24, pp. 900, 2010.DOI: https://doi.org/10.34238/tnu-jst.6388
Refbacks
- There are currently no refbacks.





